Compare Novavax Inc (NVAX) vs First Trust Cloud Computing ETF (SKYY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs First Trust Cloud Computing ETF — how do they compare? Novavax Inc trades at $12.75 (market cap $1.82B), while First Trust Cloud Computing ETF trades at $174.89 (market cap $3.47B). The key difference: First Trust Cloud Computing ETF is the larger of the two by market cap, and First Trust Cloud Computing ETF is more actively traded (176,159 versus 6,198,505). Which is the better fit depends on your goals — on Pluang, investors hold Novavax Inc for 59 Days and First Trust Cloud Computing ETF for 85 Days on average.
| NVAX | SKYY | |
|---|---|---|
Market Cap | $1.82B | $3.47B |
Volume | 6,198,505 | 176,159 |
Sector | Health | — |
52-Week High | $12.56 | $171.01 |
52-Week Low | $6.22 | $104.16 |
Typical Hold Time | 59 Days | 85 Days |
Enterprise Value | $1.39B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $11.01, down 1.87% on the day, with a bullish technical signal from moving averages and strong analyst support (73.9% buy ratings). The company reported revenue of $1.12B in 2025 with a net income of $440.3M, marking a significant turnaround from prior losses, though 2026 projections show a return to negative net income. Recent news highlights regulatory approvals for its COVID-19 vaccine and strategic pivots toward its Matrix-M adjuvant platform through partnerships.
The outlook is mixed: strong valuation ratios (P/E of 3.14, EV/EBITDA of 1.72) and recent earnings beats suggest undervaluation, but persistent cash burn and negative equity pose risks. Investment opportunity lies in partnership-driven growth, while risks include execution challenges and reliance on vaccine demand. Wall Street sentiment remains optimistic despite fundamental volatility.
SKYY (First Trust Cloud Computing ETF) trades at $174.885, up 2.4% with strong bullish technical signals from moving averages. The ETF recently hit a 52-week high, benefiting from AI-driven cloud computing demand. Technical indicators show bullish momentum with support at $169 and resistance at $171. The fund provides diversified exposure to cloud infrastructure and software companies without heavy concentration in mega-cap tech stocks.
The outlook remains positive as cloud computing benefits from secular trends including AI adoption and digital transformation. Key risks include sector concentration and market volatility. Institutional activity shows mixed sentiment with some firms trimming positions while broader analyst coverage highlights the ETF's strategic positioning in the growing cloud computing market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About First Trust Cloud Computing ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →
